Arrowstreet Capital’s InflaRx IFRX Stock Holding History

Arrowstreet Capital’s Portfolio IFRX Stock Details IFRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-49,500	Closed	-$227K	–	2406
2020 Q2	$227K	Buy	+49,500	New	+$321K	﹤0.01%	2153

Other funds holding IFRX

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

SFI

Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return

Arrowstreet Capital's IFRX Position: Q3 2020 in Review

Arrowstreet Capital sold out of InflaRx (IFRX) in Q3 2020, closing a stake of 49,500 shares — an estimated $227K sold.

Arrowstreet Capital first reported a position in IFRX in Q2 2020 and held it in 1 quarter. The position peaked at $227K in Q2 2020. 28 funds tracked by Wall St. Rank hold IFRX as of Q3 2020.

Arrowstreet Capital reported no remaining InflaRx position as of Q3 2020 after selling out during the quarter.
Arrowstreet Capital sold 49,500 InflaRx shares in Q3 2020, an estimated $227K.
Arrowstreet Capital first reported a position in InflaRx in Q2 2020 and held it in 1 quarter.
Arrowstreet Capital's InflaRx position peaked at $227K in Q2 2020.
28 funds tracked by Wall St. Rank held InflaRx as of Q3 2020.

Based on Arrowstreet Capital's 13F filing for Q3 2020, filed 12 Nov 2020.